The current state of mono-blister solutions

About the webinar

The majority of established blister pack solutions for oral solid doses are  considered neither recyclable nor sustainable. Some incumbent solutions contain problematic substances like PFAS or halogens, which raises concern about the end-of-life of the packaging. The pharma industry is also searching for ways how to reduce their emissions. The upcoming plastic packaging waste regulation and changes in the extended producer responsibility are also drivers for this development change. 

The webinar is providing guidance on the current state of the technology, the different low- to medium barrier solutions and the performance in terms of barrier properties and processing. 

Watch on demand

Companion White Paper

Download Colin Reed’s White Paper, The Future of Sustainable Pharmaceutical Blister Packaging, below. It covers the topics he discusses during the webinar.

Download the White Paper

Learning Objectives

1. Get an overview of the current blister market and an outlook for the future development of non-PVC blister solutions
2. Gain insights in Novartis’ sustainable packaging strategy and key insights in the work they have done to assess alternatives to current PVC-AL blisters
3. Learn how EPR-fees for different blister materials will have an impact on the total cost of ownership in different regions

Watch on demand

Colin Reed

Managing Director
Reap Consulting Ltd.

Colin Reed has 25 years of experience in the packaging industry, including operational and BU leadership, strategy and marketing, and M&A. He is the Managing Director of the UK-based consultancy offering Reap Consulting and is offering global advisory and project management services to the pharmaceutical and medical device packaging industries.

Dr. Markus Reichle

Senior Consultant
Iticon GmbH

Dr. Markus Reichle has more than 12 years of experience in consulting and has spent more than 6 years providing technology and market intelligence services to the chemical and pharmaceutical industries. He covers a wide range of topics, including sustainable materials, circularity, PFAS, and companion diagnostics, among others. His responsibilities in the pharma and medical devices industries include developing sustainability scorecards for polymer materials, analyzing global recycling regulations, and identifying and evaluating suppliers and technology providers based on client-specific criteria.

Markus Schönfeld

Project Leader Packaging and Device Development
Novartis Pharma AG

Markus Schoenfeld is the Project Leader for Packaging and Device Development at Novartis, a global healthcare company. With a focus on pharmaceutical manufacturing, Markus is an expert in the complexities of blister packaging, particularly in meeting varying market demands and regulatory requirements. He has deep insights into the design and development of blister processes for new and existing products, emphasizing the importance of balancing child safety and user-friendliness. products, where he considers pharmaceutical performance as a critical factor.

Elisabeth Skoda

Editor at Large
Packaging Europe

Coming from a background of translation and online news editing, Elisabeth has been with Packaging Europe since 2006, and in this time has developed a broad understanding of the packaging industry and an appreciation of the numerous innovations and developments that have come up over the years. An experienced multilingual journalist, editor and podcast host, Elisabeth has a keen interest in packaging functionality and the consumer experience.